Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

loss of exclusivity

This page shows the latest loss of exclusivity news and features for those working in and with pharma, biotech and healthcare.

Gilead’s Q1 revenues lifted by COVID-19 med Veklury as HIV drugs take a hit

Gilead’s Q1 revenues lifted by COVID-19 med Veklury as HIV drugs take a hit

However, total product sales excluding Veklury dropped by 11% to $4.9bn compared to Q1 2020, due to the loss of exclusivity of its HIV drugs Truvada, tenofovir disoproxil fumarate and ... Gilead added that sales of Veklury would also continue to be

Latest news

  • New data keeps AbbVie’s star pipeline therapies on track New data keeps AbbVie’s star pipeline therapies on track

    when it came to keeping patients in work without loss of productivity caused by the skin disorder. ... The prospects for risankizumab and upadacitinib matter for AbbVie because it’s well-recognised that the loss of exclusivity for Humira after 2022 in

  • Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate

    Biosimilar companies are now gearing up to pounce on AbbVie’s inflammation blockbuster Humira (adalimumab) when it loses its patent exclusivity across Europe on 16 October. ... As the potential savings are so great, NHS England’s Commercial Medicines

  • Pfizer builds gap between pharma and consumer health units Pfizer builds gap between pharma and consumer health units

    Its consumer health division will become a standalone unit after lack of buyer interest. ... the loss of market exclusivity for older, big-selling drugs.

  • The new basics The new basics

    This is most immediately obvious in the first - the threat of lost reputation. ... This beneficial combination of factors seems to be changing however. Profit streams erode quickly with loss of exclusivity of blockbusters and even patented products face

  • Sweet emotion Sweet emotion

    Branded medication continues to get prescribed even after loss of exclusivity. ... In the pharma sector specifically, we know branded medication continues to get prescribed even after loss of exclusivity.

More from news
Approximately 0 fully matching, plus 53 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    The loss of exclusivity for Lipitor continued to have a major impact, but alongside this, a further 24 of its therapies suffered a drop in sales. ... in an attempt to mirror the success of Roche and its Genentech subsidiary.”.

  • Who tops the pharma list? Who tops the pharma list?

    Loss of exclusivity on some of its leading brands - not least Lipitor - contributed to an overall dip in revenue of more than $6.5bn from 2011. ... In fact, patent expiry was an industry-wide epidemic in 2011/12, with loss of exclusivity plaguing many of

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    Major products were about to lose, or had just lost, their patent exclusivity.”. ... For Nycomed this meant loss of exclusivity (LOE) on its blockbuster gastroinestinal drug pantoprazole and the consequent need to reorganise its business.

  • The true meaning of market access? The true meaning of market access?

    Appropriate patients. Payers want predictability of patient outcomes and certainty of budget impact. ... Market access is everyone's responsibility throughout the life of the medicine from early phase R&D right through to loss of exclusivity.  .

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...

Quick links